Isocitrate dehydrogenase expression is diminished in a mouse model of Alzheimer’s disease, and the administration of an antisense nucleotide targeting β-amyloid reduced oxidative stress-induced damage, possibly by an increased expression of isocitrate dehydrogenase [35]. Here, IDH3A is linked to Alzheimer disease.